Price Chart
Key Statistics
Previous Close
$30.21Day Range
52-Week Range
Avg Volume
11.9KDividend Yield
1.27%Expense Ratio
0.59%AUM
$55.1MShares Outstanding
1.3METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 43.26% |
| China | 18.62% |
| Denmark | 17.40% |
| Japan | 6.09% |
| South Korea | 4.44% |
| United Kingdom | 3.92% |
| Switzerland | 3.31% |
| Hong Kong | 2.87% |
| Other | 0.09% |
Fund Information
- Issuer
- Roundhill Investments
- Category
- Healthcare
- Types
- Pharma
- Inception Date
- May 21, 2024
- Exchange
- NASDAQ
- Description
- Roundhill believes that weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry. The Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM is an actively-managed ETF.
Similar ETFs
The Roundhill Investments - GLP-1 & Weight Loss ETF (OZEM) is an exchange-traded fund issued by Roundhill Investments that launched on May 21, 2024. It currently manages $55.1M in assets under management. The fund charges an expense ratio of 0.59%. The fund holds 29 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 68.2% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | 14.35% | 6,323 | $7.9M |
| 2 | NVO | Novo Nordisk A/S | 12.00% | 168,720 | $6.6M |
| 3 | PFE | Pfizer Inc | 8.30% | 155,443 | $4.6M |
| 4 | 1093.HK | CSPC Pharmaceutical Group Ltd | 6.00% | 2,930,000 | $3.3M |
| 5 | KLRA | Kailera Therapeutics Inc | 5.54% | 260,799 | $3.1M |
| 6 | 4519.T | Chugai Pharmaceutical Co Ltd | 4.85% | 67,500 | $2.7M |
| 7 | VKTX | Viking Therapeutics Inc | 4.80% | 96,697 | $2.6M |
| 8 | AMGN | Amgen Inc | 4.70% | 5,971 | $2.6M |
| 9 | AZN | AstraZeneca PLC | 4.08% | 13,509 | $2.3M |
| 10 | ROP.SW | Roche Holding AG | 3.56% | 4,286 | $2.0M |
| 11 | 128940.KS | Hanmi Pharm Co Ltd | 3.52% | 6,768 | $1.9M |
| 12 | ZEAL.CO | Zealand Pharma A/S | 3.44% | 55,165 | $1.9M |
| 13 | 1672.HK | Ascletis Pharma Inc | 3.18% | 2,375,000 | $1.8M |
| 14 | 1276.HK | Jiangsu Hengrui Pharmaceuticals Co Ltd | 2.90% | 261,600 | $1.6M |
| 15 | 3933.HK | United Laboratories International Holdings Ltd/The | 2.76% | 1,644,000 | $1.5M |
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | -0.98% | |
| 1W | +4.40% | |
| 1M | -6.72% | |
| 3M | -7.52% | |
| 6M | -2.70% | |
| YTD | -12.64% | |
| 1Y | +9.03% | |
| 3Y | +18.24% | |
| 5Y | +18.24% |
Moving Averages
$29.95
Below 20-Day MA$31.62
Below 50-Day MA$32.33
Below 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$37.01
Current Price
$29.91
52-Week Low
$27.51
Current Yield
1.27%
Annual Dividend
$0.8729
Frequency
1x/year
Last Ex-Date
Dec 30, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 30, 2025 | $0.4099 | Dec 31, 2025 |
| Dec 30, 2025 | $0.4099 | Dec 31, 2025 |
| Dec 30, 2024 | $0.0531 | Dec 31, 2024 |
Dividend Payments Over Time
Category Comparison
| Metric | OZEM | Healthcare(205 ETFs) | Pharma(29 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.59% | 0.64% | 0.67% |
| AUM | $55.1M | $868.4M | $1.78B |
| Dividend Yield | 1.27% | 4.50% | 1.81% |
| Avg Volume | 11.9K | 264.1K | 425.1K |
| Holdings | 29 | 145 | 38 |
| Performance | |||
| 1-Month Return | -6.72% | -1.96% | -1.75% |
| 6-Month Return | -0.37% | +10.01% | +14.81% |
| YTD Return | -12.18% | +11.25% | +14.13% |
| 1-Year Return | -15.78% | +7.17% | +12.43% |
Compare with Another ETF
Search for an ETF to compare with OZEM:
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.